Hiroz P, Gouttenoire J, Dao Thi V L, Sahli R, Telenti A, Moradpour D, Doerig C
Service de gastroentérologie et d'hépatologie, CHUV, 1011 Lausanne.
Rev Med Suisse. 2013 Sep 4;9(396):1594, 1596-8.
The hepatitis E virus (HEV) is an RNA virus transmitted via the fecal-oral route or through uncooked animal meat products. Of the 4 known genotypes, genotype 3 is responsible for autochthonous infections in industrialized countries, with a seroprevalence in Switzerland estimated as high as 22%. The majority of infections is asymptomatic but a minority of patients, notably men over 50 or with underlying liver disease, can present with severe acute hepatitis. Chronic hepatitis E with HEV of genotype 3 has been observed in immunosuppressed patients, mostly transplant recipients. Serology is not sufficiently sensitive, especially in immunosuppressed patients, making PCR identification the preferred test for diagnosing active infection. Ribavirin or interferon-alpha can be used to treat chronic hepatitis E if reduction of immunosuppressive treatment does not result in viral elimination.
戊型肝炎病毒(HEV)是一种通过粪口途径或未煮熟的动物肉制品传播的RNA病毒。在已知的4种基因型中,3型基因型在工业化国家导致本土感染,瑞士的血清流行率估计高达22%。大多数感染是无症状的,但少数患者,尤其是50岁以上或有潜在肝脏疾病的男性,可能会出现严重的急性肝炎。在免疫抑制患者中,主要是移植受者,已观察到3型基因型HEV导致的慢性戊型肝炎。血清学检测不够灵敏,尤其是在免疫抑制患者中,这使得PCR鉴定成为诊断活动性感染的首选检测方法。如果减少免疫抑制治疗不能消除病毒,利巴韦林或干扰素-α可用于治疗慢性戊型肝炎。